Exploring CBT-DM's Absoulte and Relative Efficacy for Depressed T1DM Latino Youth

探索 CBT-DM 对抑郁 T1DM 拉丁裔青年的绝对和相对功效

基本信息

  • 批准号:
    8175970
  • 负责人:
  • 金额:
    $ 18.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-15 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is an R03 (PAR-09-223) application submitted to NIDDK. This study entails the revision of the 12-session Group Cognitive Behavioral Therapy (CBT-DM) manual for depressed Type 1 Diabetes Mellitus (T1DM) Latino youth, and explores both the absolute efficacy of CBT-DM against a treatment as usual (TAU) condition, and the added impact of CBT-DM over the original culturally-adapted CBT for depression. After initial manual revision by our expert team, in-depth interviews with diabetes treatment providers, and a small pre-pilot study with 8 depressed T1DM Latino youth and their parents will be conducted to inform the revision of and further refine CBT-DM treatment manual. Focus groups with youth and parents in the small pre-pilot study will serve to complete the refinement process. Finally, 60 depressed T1DM youth will be randomized to one of three conditions: CBT-DM, CBT for depression, and TAU. Treatment efficacy will be assessed by comparing changes on depression, self-esteem and functionality scores, diabetes self-efficacy and quality of life, and treatment adherence and self-care management of T1DM. We propose that both CBT-DM and CBT will be superior to TAU in reducing depression, and improving self-esteem and functionality. We also hypothesize that CBT-DM will be superior to the other conditions in domains related to T1DM (diabetes self-efficacy, quality of life, treatment adherence and self-care behaviors). Intake data will be obtained with structured diagnostic interviews, self-report scales and laboratory tests of glycosylated hemoglobin (HbA1c). We will assess youth T1DM health and treatment adherence information, mental health (including depression) diagnostic status, youth cognitive and affective variables, parent and family functioning, and family knowledge about youth depression and T1DM. We will also evaluate the feasibility and acceptability of treatment, the adequacy of randomization, attrition rates, therapist competence and treatment integrity. The assessment will be conducted at baseline, at weeks 5, 9 and 12 (post-treatment), and at the three- and six-month follow-ups. This investigation is the second step in a research program aimed to bring the benefits of evidence-based treatment (EBT) development to Latino youth with comorbid T1DM and depression, and set the stage for a larger-scale and definite study of treatment efficacy (R01). This study is innovative because it is the first that could potentially contribute to provide initial evidence in support of the probably-efficacious status of a psychosocial intervention aimed at both improving diabetes health status and reducing depressive symptoms in youth. The revised CBT-DM manual for T1DM Latino youth would also be an innovative clinical tool that could enhance the prevention of mood disorders and the reduction of health disparities in this minority group. PUBLIC HEALTH RELEVANCE: This study is likely to shed light on whether a novel intervention combining CBT with diabetes education for youth can reduce the morbidity observed in those with co-morbid T1DM and depression and achieve positive diabetes outcomes, as opposed to Treatment as usual (TAU) and CBT for depression. It will be the first to develop/adapt and pilot-test (in a small Randomized Clinical Trial-type design) a culturally-sensitive intervention specifically tailored to Latino youth with co-morbid T1DM and depression, and if proven to be promising, it will make it attractive for administrators to implement it in primary care and mental health settings serving the Latino pediatric population. This research will potentially help to close knowledge gaps in treatment research with T1DM Latino children and impact other behavioral, cognitive, and affective factors that add on the burden of diabetes in this vulnerable and underserved group.
描述(由申请人提供):这是提交给NIDDK的R 03(PAR-09-223)申请。这项研究需要修订12届小组认知行为治疗(CBT-DM)手册抑郁症1型糖尿病(T1 DM)拉丁裔青年,并探讨CBT-DM对治疗照常(TAU)条件的绝对疗效,以及CBT-DM对抑郁症的原始文化适应CBT的额外影响。在我们的专家团队进行初步手册修订后,将对糖尿病治疗提供者进行深入访谈,并对8名抑郁的T1 DM拉丁裔青年及其父母进行小型预试验研究,以了解CBT-DM治疗手册的修订和进一步完善。在小型试点前研究中与青年和家长组成的重点小组将有助于完成完善过程。最后,60名抑郁的T1 DM青年将被随机分配到三种情况之一:CBT-DM,CBT抑郁症和TAU。将通过比较抑郁、自尊和功能评分、糖尿病自我效能和生活质量以及T1 DM的治疗依从性和自我护理管理的变化来评估治疗疗效。我们认为CBT-DM和CBT在减少抑郁、提高自尊和功能方面都上级TAU。我们还假设CBT-DM在与T1 DM相关的领域(糖尿病自我效能、生活质量、治疗依从性和自我护理行为)上级其他疾病。将通过结构化诊断访谈、自我报告量表和糖化血红蛋白(HbA 1c)实验室检查获得摄入数据。我们将评估青年T1 DM健康和治疗依从性信息,心理健康(包括抑郁症)诊断状态,青年认知和情感变量,父母和家庭功能,以及家庭对青年抑郁症和T1 DM的了解。我们还将评估治疗的可行性和可接受性、随机化的充分性、损耗率、治疗师的能力和治疗的完整性。将在基线、第5、9和12周(治疗后)以及3个月和6个月随访时进行评估。这项调查是一项研究计划的第二步,旨在为患有T1 DM和抑郁症的拉丁裔青年带来循证治疗(EBT)发展的益处,并为更大规模和明确的治疗疗效研究(R 01)奠定基础。这项研究是创新的,因为它是第一个可能有助于提供初步证据,支持旨在改善糖尿病健康状况和减少青年抑郁症状的心理社会干预的可能有效状态。修订后的T1 DM拉丁裔青年CBT-DM手册也将是一个创新的临床工具,可以加强预防情绪障碍和减少这一少数群体的健康差距。 公共卫生相关性:这项研究可能揭示了一种新的干预措施,将CBT与青年糖尿病教育相结合,是否可以降低合并T1 DM和抑郁症患者的发病率,并实现积极的糖尿病结局,而不是像往常一样治疗(TAU)和CBT治疗抑郁症。这将是第一个开发/适应和试点测试(在一个小型随机临床试验类型的设计)一个文化敏感的干预措施,专门针对患有合并症的T1 DM和抑郁症的拉丁美洲青年,如果被证明是有前途的,它将使管理员有吸引力,在初级保健和精神卫生环境中实施它,为拉丁美洲儿科人群服务。这项研究可能有助于缩小T1 DM拉丁裔儿童治疗研究中的知识差距,并影响其他行为,认知和情感因素,这些因素增加了这个脆弱和服务不足群体的糖尿病负担。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eduardo Cumba其他文献

Eduardo Cumba的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eduardo Cumba', 18)}}的其他基金

Exploring CBT-DM's Absoulte and Relative Efficacy for Depressed T1DM Latino Youth
探索 CBT-DM 对抑郁 T1DM 拉丁裔青年的绝对和相对功效
  • 批准号:
    8332355
  • 财政年份:
    2011
  • 资助金额:
    $ 18.4万
  • 项目类别:
Exploring CBT-DM's Absoulte and Relative Efficacy for Depressed T1DM Latino Youth
探索 CBT-DM 对抑郁 T1DM 拉丁裔青年的绝对和相对功效
  • 批准号:
    8546344
  • 财政年份:
    2011
  • 资助金额:
    $ 18.4万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 18.4万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了